GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Total Receivables

Biotest AG (XTER:BIO3) Total Receivables : €170.0 Mil (As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Total Receivables?

Biotest AG's Total Receivables for the quarter that ended in Sep. 2024 was €170.0 Mil.


Biotest AG Total Receivables Historical Data

The historical data trend for Biotest AG's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Total Receivables Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.40 168.70 152.30 168.60 199.30

Biotest AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 254.50 199.30 246.50 170.90 170.00

Biotest AG Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Biotest AG Total Receivables Related Terms

Thank you for viewing the detailed overview of Biotest AG's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG Business Description

Traded in Other Exchanges
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.
Executives
Dr. Katrin Bernöster Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke Senior Vice President plasma alliances and proteine supply
Stephan Fleck Vice President Corporate Controlling
Dr. Jörg Schüttrumpf VP Corp. Research &Development
Michael Moritz VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines